Trans-Iliac Aortic Valve Replacement: Feasibility, Safety, and Medium-Term Follow-up

Open journal of cardiovascular surgery

20 June Jun 2019 3 months ago
  • Gennari M, Trabattoni P, Pepi M, Polvani G, Salvi L, Agrifoglio M

Transcatheter aortic valve replacement (TAVR) is nowadays generally accepted as the treatment of choice for high- to intermediate-risk patients with severe aortic stenosis not suitable for the standard surgical replacement. Many vascular accesses have been described for the valve delivery, comprising the common iliac artery as the arterial site of access.

Reference

Gennari M, Trabattoni P, Pepi M, Polvani G, Salvi L, Agrifoglio M. Trans-Iliac Aortic Valve Replacement: Feasibility, Safety, and Medium-Term Follow-up. Open J Cardiovasc Surg 2019 Jun 2;11:1179065219853582. doi: 10.1177/1179065219853582

Go to PubMed